Company: INTS
Filing Date: 2025-01-07
Form Type: CORRESP
Source: 0001567264-25-000003
Chunk: 1

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-01-07
Form: CORRESP
Chunk 1
---
 |     |   |                              |   267 |
| Stock-based compensation                   |                |   |                                      |   970 |     |   |                              |   714 |
| Research and development expenses          |                | $ |                                8,529 |       |     | $ |                        4,786 |       |

Please contact me at (203) 221-7377 if you have any questions or require any additional information in connection with this letter.

| Sincerely,                                           |
| Intensity Therapeutics, Inc.                         |
| /s/ Lewis H. Bender                                  |
| Lewis H. Bender, President & Chief Executive Officer |

cc: Joseph Talamo, Chief Financial Officer

Jeffrey Schultz, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Kostantinos Skordalos, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.